Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.61 |
| ▸ | ALOX5 | P09917 | 3/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.54 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.54 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8108303 | 0.98 | MAPT (0.64) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL7864099 | 0.98 | MAPT (0.64) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL8123200 | 0.98 | MAPT (0.64) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL1478009 | 0.93 | HDAC1 (0.61) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL2162299 | 0.84 | MAPT (0.59) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL16274 | 0.83 | ALDH1A1 (0.67) | MAPTHDAC1HDAC2ADRA1ASLC6A3 | |
| SCHEMBL3456971 | 0.83 | MAPT (0.57) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL1105483 | 0.83 | ALDH1A1 (0.73) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL11210743 | 0.83 | MAPT (0.62) | MAPTRXFP1ALOX5HDAC1HDAC2 | |
| SCHEMBL2162467 | 0.83 | MAPT (0.62) | MAPTRXFP1ALOX5HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-1186861-A | — | — | None | — | — | JP | disclosed |
| EP-1129070-A4 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL MYERS SQUIBB CO (US) | 2005-03-02 | — | — | EP | disclosed |
| EP-1404325-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2004-04-07 | — | — | EP | disclosed |
| WO-2002096420-A2 | METHOD FOR TREATING NERVE INJURY CAUSED BY SURGERY | GUILFORD PHARMACEUTICALS INC. (US) | 2002-12-05 | — | — | WO | disclosed |
| CN-1336930-A | Bridged heterocyclic derivatives | GPINIL HOLDING CORP (US) | 2002-02-20 | — | — | CN | disclosed |
| EP-1129070-A1 | NEUROTROPHIC DIAMIDE AND CARBAMATE AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-09-05 | — | — | EP | disclosed |
| EP-1127049-A1 | BRIDGED HETEROCYCLIC DERIVATIVES | GPI NIL Holdings, Inc. (US) | 2001-08-29 | — | — | EP | disclosed |
| EP-1105130-A2 | HETEROCYCLIC ESTERS OR AMIDES FOR VISION AND MEMORY DISORDERS | GPI NIL Holdings, Inc. (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-1105112-A2 | COMPOSITIONS AND USES FOR VISION AND MEMORY DISORDERS | GPI NIL Holdings, Inc. (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-1085853-A1 | HETEROCYCLIC ESTER AND AMIDE HAIR GROWTH COMPOSITIONS AND USES | GPI NIL Holdings, Inc. (US) | 2001-03-28 | — | — | EP | disclosed |
| EP-0934287-A4 | HETEROCYCLIC ESTERS AND AMIDES | GUILFORD PHARM INC (US) | 2000-01-12 | — | — | EP | disclosed |
| WO-1999062487-A1 | HETEROCYCLIC ESTER AND AMIDE HAIR GROWTH COMPOSITIONS AND USES | GPI NIL HOLDINGS, INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| EP-0934287-A1 | HETEROCYCLIC ESTERS AND AMIDES | GUILFORD PHARMACEUTICALS INC. (US) | 1999-08-11 | — | — | EP | disclosed |
| WO-1999014998-A2 | METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS | AMGEN INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| WO-1998055090-A1 | HAIR GROWTH COMPOSITIONS AND USES | GUILFORD PHARMACEUTICALS INC. (US) | 1998-12-10 | — | — | WO | disclosed |
| US-5801187-A | AFFINITY FOR FKBP-TYPE IMMUNOPHILINS | GPI-NIL HOLDINGS, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| WO-1998013355-A1 | HETEROCYCLIC ESTERS AND AMIDES | GUILFORD PHARMACEUTICALS INC. (US) | 1998-04-02 | — | — | WO | disclosed |
| US-5496853-A | FOR TREATING HYPERCHOLESTEROLEMIA | TEIJIN LIMITED (JP) | 1996-03-05 | — | — | US | disclosed |
| EP-0632031-A1 | CONDENSED BENZOXA RING COMPOUND, PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | TEIJIN LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| JP-H01186861-A | PEROXY ESTER COMPOUND, PRODUCTION THEREOF AND TEST COMPOSITION AND TEST TOOL USING SAID COMPOUND | TERUMO CORP | 1989-07-26 | — | — | JP | disclosed |